Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 982 | 883 | 982 | 928 | 1292 | 1730 |
Fund Return | -1.79% | -11.7% | -1.79% | -2.45% | 5.26% | 5.63% |
Place in category | 641 | 678 | 641 | 264 | 120 | 121 |
% in Category | 65 | 69 | 65 | 42 | 24 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund C div USD hedged | 18.35B | 8.94 | 1.79 | 4.58 | ||
Global Income Fund D div USD hedged | 18.21B | 7.79 | 0.73 | 3.50 | ||
JPI Global Income Fund A acc USD he | 18.21B | 8.20 | 1.11 | 3.89 | ||
JPI Global Income Fund A div USD he | 18.21B | 8.23 | 1.12 | 3.90 | ||
JPI Global Income Fund A mth USD he | 18.21B | 8.19 | 1.10 | 3.87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund A2 | 13.1B | 1.94 | -0.42 | 6.99 | ||
World Healthscience Fund E2 | 13.1B | 1.43 | -0.92 | 6.46 | ||
LU1960219225 | 13.1B | 2.96 | 0.56 | - | ||
LU2112291526 | 13.1B | 1.95 | -0.42 | - | ||
World Healthscience Fund C2u | 13.1B | 0.67 | -1.67 | 5.66 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.74 | 870.37 | +3.35% | |
UnitedHealth | US91324P1021 | 8.39 | 530.04 | -1.81% | |
AbbVie | US00287Y1091 | 6.03 | 192.97 | +0.64% | |
AstraZeneca | GB0009895292 | 4.66 | 11,606.0 | -1.53% | |
Novo Nordisk B | DK0062498333 | 4.22 | 638.0 | +0.47% |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review